Yoichiro Moriya - Concepedia

Author

Yoichiro Moriya

Also Known As

Satoshi Sakaguchi, Y Moriya, Y. MORIYA, Y. Moriya, Y.-i. Moriya, YOICHIRO MORIYA, Yoichiro MORIYA, Yoichiro Moriya, Yugo Moriya

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Tokushima University Chugai Pharma (United States)The University of Osaka

About

Yoichiro Moriya is an author at Tokushima University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	993
2	Allergy	6	6	229
3	Health Sciences	3	3	104
4	Biochemistry	2	2	59
5	Biomolecular Engineering	1	1	16

Yoichiro Moriya

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis Nobuhiro Takagi, Masahiko Mihara, Yoichiro Moriya, Arthritis & Rheumatism	1998	273
INTERLEUKIN-6 (IL-6) INDUCES THE PROLIFERATION OF SYNOVIAL FIBROBLASTIC CELLS IN THE PRESENCE OF SOLUBLE IL-6 RECEPTOR Masahiko Mihara, Yoichiro Moriya, Tadamitsu Kishimoto, Lara D. Veeken InflammationRheumatologyCytokineRheumatoid DisorderAutoimmune Disease	1995	201
Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models Kaori Fujimoto-Ouchi, Fumiko Sekiguchi, Hideyuki Yasuno, Cancer Chemotherapy and Pharmacology Tumor BiologyOncologyAntitumor ActivityMedicineImmune Checkpoint Inhibitor	2006	192
Expression of Toll-Like Receptor 4 on Dendritic Cells Is Significant for Anticancer Effect of Dendritic Cell-Based Immunotherapy in Combination with an Active Component of OK-432, a Streptococcal Preparation Masato Okamoto, Sachiko Furuichi, Yasuhiko Nishioka, Cancer Research	2004	115
Involvement of Toll-Like Receptor 4 Signaling in Interferon- Production and Antitumor Effect by Streptococcal Agent OK-432 Masahiro Okamoto, Tetsuya Oshikawa, T. Tano, JNCI Journal of the National Cancer Institute	2003	81
Mechanism of Anticancer Host Response Induced by OK-432, a Streptococcal Preparation, Mediated by Phagocytosis and Toll-Like Receptor 4 Signaling Masato Okamoto, Tetsuya Oshikawa, Tomoyuki Tano, Journal of Immunotherapy	2005	71
Biological effect of OK-432 (picibanil) and possible application to dendritic cell therapy. Yoshiki Ryoma, Yoichiro Moriya, Masato Okamoto, PubMed Innate Immune SystemImmunologyCell DeathBiological TherapyInnate Immunity	2004	60
A role of cytokines in OK-432 injection therapy for cystic lymphangioma: an approach to the mechanism Akihiro Fujino, Yoichiro Moriya, Yasuhide Morikawa, Journal of Pediatric Surgery InflammationAutoimmune DiseaseOk-432 Injection TherapyMedicineImmune Regulation	2003	51
Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed Streptococcal preparation Motoo Saito, Osamu Ichimura, Motoyuki Kataoka, Cancer Immunology Immunotherapy InflammationMucosal VaccinationMedicineKilled Streptococcal PreparationImmunology	1986	49
Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292 Koh Furugaki, Yoichiro Moriya, Toshiki Iwai, Clinical & Experimental Metastasis	2011	49

Page 1